mid term +7,000%
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel technologies and therapeutics for the treatment of the central nervous system, respiratory, and other disorders.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.